New medicines in our portfolio

  1. Tecfidera (dimethyl fumarate)
    Tecfidera (dimethyl fumarate)
    by Biogen
    for Multiple Sclerosis
    €1,148.50
  2. Mayzent (siponimod)
    Mayzent (siponimod)
    by Novartis
    for Multiple Sclerosis
    €20,985.00
  3. Tudcabil (tauroursodeoxycholic acid)
    Tudcabil (tauroursodeoxycholic acid)
    by Bruschettini s.r.l.
    for Amyotrophic Lateral Sclerosis (ALS)
    €22.38
  4. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by
    for Skin Cancer
    €17,380.00
View as Grid List

4 Items

per page
Set Descending Direction